Immunity to Marek's disease: Where are we now?

Developmental and Comparative Immunology

Volumn 41, Issue 3, 2013, Pages 439-446

  Haq, Kamran ^a,c,d   Schat, Karel A ^b   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b Cornell University ^*  (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chickens; Cytokines; Immune response; Marek's disease; RNAi; Vaccines

Indexed keywords

ANTIBODY; CYTOKINE; MARDIVIRUS VACCINE; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CELLULAR IMMUNITY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DRUG EFFICACY; DRUG FORMULATION; GENE MAPPING; GENE SEQUENCE; IMMUNITY; IMMUNOREGULATION; INNATE IMMUNITY; MARDIVIRUS; MAREK DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS TRANSMISSION;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

CHICKENS; CTL; CYTOKINES; CYTOTOXIC T-LYMPHOCYTES; GB; GLYCOPROTEIN; HERPESVIRUS OF TURKEYS; HVT; IFN; IL; IMMUNE RESPONSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INOS; INTERFERON; INTERLEUKIN; LIPOPOLYSACCHARIDES; LPS; MAJOR HISTOCOMPATIBILITY COMPLEX; MAREK'S DISEASE; MAREK'S DISEASE VIRUS; MD; MDV; MESSENGER RNA; MHC; MRNA; NITRIC OXIDE; NO; PATTERN RECOGNITION RECEPTOR; PRR; RNA INTERFERENCE; RNAI; TLR; TOLL-LIKE RECEPTORS; VACCINES;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOME; HERPESVIRUS 2, GALLID; HOST-PATHOGEN INTERACTIONS; IMMUNITY, ACTIVE; IMMUNITY, INNATE; LYMPHOCYTES; MAREK DISEASE; TRANSCRIPTOME; VACCINATION; VIRAL VACCINES;

EID: 84883052233     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2013.04.001     Document Type: Article

References (116)

1. Abdul-Careem M.F., Hunter B.D., Sarson A.J., Mayameei A., Zhou H., Sharif S. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunol. 2006, 19:167-176.
2. Abdul-Careem M.F., Hunter B.D., Parvizi P., Haghighi H.R., Thanthrige-Don N., Sharif S. Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. Vaccine 2007, 25:424-432.
3. Abdul-Careem M.F., Hunter B.D., Sarson A.J., Parvizi P., Haghighi H.R., Read L., Heidari M., Sharif S. Host responses are induced in feathers of chickens infected with Marek's disease virus. Virology 2008, 370:323-332.
4. Abdul-Careem M.F., Javaheri-Vayeghan A., Shanmuganathan S., Haghighi H.R., Read L.R., Haq K., Hunter B.D., Schat K.A., Heidari M., Sharif S. Establishment of an aerosol-based Marek's disease virus infection model. Avian Dis. 2009, 53:387-391.
5. Abdul-Careem M.F., Haq K., Shanmuganathan S., Read L.R., Schat K.A., Heidari M., Sharif S. Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek's disease virus. Virology 2009, 393:250-257.
6. Aktan F. INOS-mediated nitric oxide production and its regulation. Life Sci. 2004, 75:639-653.
7. Bacon L.D., Hunt H.D., Cheng H.H. Genetic resistance to Marek's disease. Curr. Top. Microbiol. Immunol. 2001, 255:121-141.
8. Barrow A.D., Burgess S.C., Baigent S.J., Howes K., Nair V.K. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus. J. Gen. Virol. 2003, 84:2635-2645.
9. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2:907-916.
10. Boyd A., Philbin V.J., Smith A.L. Conserved and distinct aspects of the avian Toll-like receptor (TLR) system: implications for transmission and control of bird-borne zoonoses. Biochem. Soc. Trans. 2007, 35:1504-1507.
11. Brownlie R., Allan B. Avian toll-like receptors. Cell Tissue Res. 2011, 343:121-130.
12. Buscaglia C., O'Connell P.H., Jarosinski K.W., Pevzner I., Schat K.A. Selection for increased nitric oxide production does not increase resistance to Marek's disease in a primary broiler breeder line. Avian Dis. 2009, 53:336-340.
13. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 1970, 14:219-233.
14. Calnek B.W. Marek's disease - a model for herpesvirus oncology. Crit. Rev. Microbiol. 1986, 12:293-320.
15. Calnek B.W. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 2001, 255:25-55.
16. Chaung H.-C., Cheng L.-T., Hung L.-H., Tsai P.-C., Skountzou I., Wang B., Compans R.W., Lien Y.-Y. Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens. Vet. Microbiol. 2011, 157:69-77.
17. Cheeseman J.H., Lillehoj H.S., Lamont S.J. Reduced nitric oxide production and iNOS mRNA expression in IFN-gamma stimulated chicken macrophages transfected with iNOS siRNAs. Vet. Immunol. Immunopathol. 2008, 125:375-380.
18. Chen M., Payne W.S., Hunt H.D., Zhang H.M., Holmen S.L., Dodgson J.B. Inhibition of Marek's disease virus replication by retroviral vector-based RNA interference. Virology 2008, 377:265-272.
19. Chen M., Payne W.S., Dunn J.R., Chang S., Zhang H.M., Hunt H.D., Dodgson J.B. Retroviral delivery of RNA interference against Marek's disease virus in vivo. Poult. Sci. 2009, 88:1373-1380.
20. Chiang H., Berghman L.R., Zhou H. Inhibition of NF-kB 1 (NF-kBp50) by RNA interference in chicken macrophage HD11 cell line challenged with Salmonella enteritidis. Genet. Mol. Biol. 2009, 32:507-515.
21. Churchill A.E., Payne L.N., Chubb R.C. Immunization against Marek's disease using a live attenuated virus. Nature 1969, 221:744-747.
22. Cumberbatch J.A., Brewer D., Vidavsky I., Sharif S. Chicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides. Anim. Genet. 2006, 37:393-396.
23. Dai F., Yusuf F., Farjah G.H., Brand-Saberi B. RNAi-induced targeted silencing of developmental control genes during chicken embryogenesis. Dev. Biol. 2005, 285:80-90.
24. Dalloul R.A., Lillehoj H.S., Okamura M., Xie H., Min W., Ding X., Heckert R.A. In vivo effects of CpG oligodeoxynucleotide on Eimeria infection in chickens. Avian Dis. 2004, 48:783-790.
25. Dar A., Potter A., Tikoo S., Gerdts V., Lai K., Babiuk L.A., Mutwiri G. CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos. Avian Dis. 2009, 53:261-267.
26. Davison T.F., Kaiser P. Immunity to Marek's disease. Marek's Disease: An Evolving Problem 2004, 126-139. Elsevier, Great Britain. V. Nair, F. Davison (Eds.).
27. Djeraba A., Bernardet N., Dambrine G., Quéré P. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology 2000, 277:58-65.
28. Djeraba A., Musset E., Bernardet N., Le Vern Y., Quere P. Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease. Vet. Immunol. Immunopathol. 2002, 85:63-75.
29. Djeraba A., Kut E., Rasschaert D., Quéré P. Antiviral and antitumoural effects of recombinant chicken myelomonocytic growth factor in virally induced lymphoma. Int. Immunopharmacol. 2002, 2:1557-1566.
30. + T cells. J. Virol. 2012, 86:8536-8545.
31. Erhard M.H., Schmidt P., Zinsmeister P., Hofmann A., Münster U., Kaspers B., Wiesmüller K.H., Bessler W.G., Stangassinger M. Adjuvant effects of various lipopeptides and interferon-gamma on the humoral immune response of chickens. Poult. Sci. 2000, 79:1264-1270.
32. Garcia-Camacho L., Schat K.A., Brooks R., Bounous D.I. Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet. Immunol. Immunopathol. 2003, 95:145-153.
33. Ge Q., McManus M.T., Nguyen T., Shen C.-H., Sharp P.A., Eisen H.N., Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2718-2723.
34. Gimeno I.M., Witter R.L., Hunt H.D., Lee L.F., Reddy S.M., Neumann U. Marek's disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression. Vet. Pathol. 2001, 38:491-503.
35. Gimeno I.M. Marek's disease vaccines: a solution for today but a worry for tomorrow?. Vaccine 2008, 26(Suppl. 3):C31-C41.
36. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 2003, 71:857-863.
37. Haeri M., Read L.R., Wilkie B.N., Sharif S. Identification of peptides associated with chicken major histocompatibility complex class II molecules of B21 and B19 haplotypes. Immunogenetics 2005, 56:854-859.
38. Haq K., Brisbin J.T., Thanthrige-Don N., Heidari M., Sharif S. Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens. Vet. Immunol. Immunopathol. 2010, 138:292-302.
39. Haq K., Elawadli I., Parvizi P., Mallick A.I., Behboudi S., Sharif S. Interferon-gamma influences immunity elicited by vaccines against very virulent Marek's disease virus. Antiviral Res. 2011, 90:218-226.
40. Haq, K., Wootton, S.K., Barjesteh, N., St. Paul, M., Golovan, S., Bendall, A., Sharif, S., in press. Small interfering RNA-mediated knockdown of chicken interferon-gamma expression. J. Interferon, Cytokine Res. Epub. PMID: 23458611.
41. Harpavat S., Cepko C.L. RCAS-RNAi: a loss-of-function method for the developing chick retina. BMC Dev. Biol. 2006, 6:2.
42. Heidari M., Sarson A.J., Huebner M., Sharif S., Kireev D., Zhou H. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling. Viral Immunol. 2010, 23:309-319.
43. Heller E.D., Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol. 1987, 16:51-60.
44. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 2002, 12:1301-1311.
45. Iqbal M., Philbin V.J., Smith A.L. Expression patterns of chicken Toll-like receptor mRNA in tissues, immune cell subsets and cell lines. Vet. Immunol. Immunopathol. 2005, 104:117-127.
46. Jarosinski K.W., Jia W., Sekellick M.J., Marcus P.I., Schat K.A. Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha. J. Interferon Cytokine Res. 2001, 21:287-296.
47. Jarosinski K.W., Njaa B.L., O'Connell P.H., Schat K.A. Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunol. 2005, 18:148-161.
48. Jenkins K.A., Lowenthal J.W., Kimpton W., Bean A.G. The in vitro and in ovo responses of chickens to TLR9 subfamily ligands. Dev. Comp. Immunol. 2009, 33:660-667.
49. Kaiser P., Underwood G., Davison T.F. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J. Virol. 2003, 77:762-768.
50. Kaiser P., Poh T.Y., Rothwell L., Avery S., Balu S., Pathania U.S., Hughes S., Goodchild M., Morell S., Watson M., Bumstead N., Kaufman J., Young J.R. A genomic analysis of chicken cytokines and chemokines. J. Interferon Cytokine Res. 2005, 25:467-484.
51. Kano R., Konnai S., Onuma M., Ohashi K. Cytokine profiles in chickens infected with virulent and avirulent Marek's disease viruses: interferon-gamma is a key factor in the protection of Marek's disease by vaccination. Microbiol. Immunol. 2009, 53:224-232.
52. Karaca G., Anobile J., Downs D., Burnside J., Schmidt C.J. Herpesvirus of turkeys: microarray analysis of host gene responses to infection. Virology 2004, 318:102-111.
53. Karpala A.J., Lowenthal J.W., Bean A.G. Activation of the TLR3 pathway regulates IFNbeta production in chickens. Dev. Comp. Immunol. 2008, 32:435-444.
54. Koch M., Camp S., Collen T., Avila D., Salomonsen J., Wallny H.J., van Hateren A., Hunt L., Jacob J.P., Johnston F., Marston D.A., Shaw I., Dunbar P.R., Cerundolo V., Jones E.Y., Kaufman J. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 2007, 27:885-899.
55. Kodama H., Mikami T., Inoue M., Izawa H. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures. J. Natl. Cancer Inst. 1979, 63:1267-1271.
56. Kodama H., Sugimoto C., Inage F., Mikami T. Anti-viral immunity against Marek's disease virus infected chicken kidney cells. Avian Pathol. 1979, 8:33-44.
57. Kogut M.H., Iqbal M., He H., Philbin V.J., Kaiser P., Smith A.L. Expression and function of Toll-like receptors in chicken heterophils. Dev. Comp. Immunol. 2005, 29:791-807.
58. Kumar S., Buza J.J., Burgess S.C. Genotype-dependent tumor regression in Marek's disease mediated at the level of tumour immunity. Cancer Microenviron. 2009, 2:23-31.
59. Lambeth L.S., Zhao Y., Smith L.P., Kgosana L., Nair V.K. Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine. Vaccine 2009, 27:298-306.
60. Levy A.M., Heller E.D., Leitner G., Davidson I. Effect of native chicken interferon on MDV replication. Acta Virol. 1999, 43:121-127.
61. Lillehoj H.S., Choi K.D. Recombinant chicken interferon-gamma-mediated inhibition of Eimeria tenella development in vitro and reduction of oocyst production and body weight loss following Eimeria acervulina challenge infection. Avian Dis. 1998, 42:307-314.
62. Long J.E., Huang L.N., Qin Z.Q., Wang W.Y., Qu D. IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection. World J. Gastroenterol. 2005, 11:4967-4973.
63. Lowenthal J.W., York J.J., O'Neil T.E., Rhodes S., Prowse S.J., Strom D.G., Digby M.R. In vivo effects of chicken interferon-gamma during infection with Eimeria. J. Interferon Cytokine Res. 1997, 17:551-558.
64. Markowski-Grimsrud C.J., Schat K.A. Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins. Vet. Immunol. Immunopathol. 2002, 90:133-144.
65. Mass H.J.L., van der Zypp A.J., Groenendal J.H., Kok G.L. Evaluation of resistance to Marek's disease in three white Plymouth Rock lines and in two reciprocal crosses. Avian Pathol. 1982, 11:1-9.
66. Mass H.J.L., Borm F., van de Kieft G. The prevention of Marek's disease in Holland by vaccination with cell-associated vaccines-CVI988 (Dutch) and FC126 (USA) - results of comparative field trials and routine vaccinations of flocks between 1970-1980. World Poult. Sci. J. 1982, 38:163-175.
67. Matsuyuma K., Murata S., Isezaki M., Kano R., Takasaki S., Ichii O., Konnai S., Ohashi K. Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek's disease virus. Virol. J. 2012, 9:94.
68. McColl K.A., Calnek B.W., Harris W.V., Schat K.A., Lee L.F. J. Natl. Cancer Inst. 1987, 79:991-1000.
69. Mester J.C., Rouse B.T. The mouse model and understanding immunity to herpes simplex virus. Rev. Infect. Dis. 1991, 13:S935-S945.
70. Morgan R.W., Sofer L., Anderson A., Bernberg E., Cui J., Burnside J. Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus. J. Virol. 2001, 75:533-539.
71. Morimura T., Ohashi K., Sugimoto C., Onuma M. Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J. Vet. Med. Sci. 1998, 60:1-8.
72. Murthy K.K., Calnek B.W. Marek's disease tumor-associated surface antigen (MATSA) in resistant versus susceptible chickens. Avian Dis. 1979, 23:831-837.
73. Nazerian K., Lee L.F., Yanagida N., Ogawa R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 1992, 66:1409-1413.
74. Nimiec P.K., Read L.R., Sharif S. Synthesis of chicken major histocompatibility complex class II oligomers using a baculovirus expression system. Protein Expr. Purif. 2006, 46:390-400.
75. Okazaki W., Purchase H.G., Burmester B.R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970, 14:413-429.
76. Omar A.R., Schat K.A. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology 1996, 222:87-99.
77. Omar A.R., Schat K.A. Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology 1997, 90:579-585.
78. Omar A.R., Schat K.A., Lee L.F., Hunt H.D. Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Vet. Immunol. Immunopathol. 1998, 62:73-82.
79. Paludan S.R., Bowie A.G., Horan K.A., Fitzgerald K.A. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 2011, 11:143-154.
80. Parvizi P., Abdul-Careem M.F., Haq K., Thanthrige-Don N., Schat K.A., Sharif S. Immune responses against Marek's disease virus. Anim. Health Res. Rev. 2010, 11:123-134.
81. Parvizi P., Andrzejewski K., Read L.R., Behboudi S., Sharif S. Expression profiling of genes associated with regulatory functions of T-cell subsets in Marek's disease virus-infected chickens. Avian Pathol. 2012, 39:367-373.
82. Parvizi P., Mallick A.I., Haq K., Haghighi H.R., Orouji S., Thanthrige-Don N., St.Paul M., Brisbin J.T., Read L.R., Behboudi S., Sharif S., Haghihghi H.R. A TLR3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumour development in chickens. Viral Immunol. 2012, 25:1-8.
83. Pekarik V., Bourikas D., Miglino N., Joset P., Preiswerk S., Stoeckli E.T. Screening for gene function in chicken embryo using RNAi and electroporation. Nat. Biotechnol. 2003, 21:93-96.
84. Powell P.C., Rennie M. Marek's disease tumour-specific antigen induced by the herpesvirus of turkeys in vaccinated chickens. Vet. Rec. 1978, 103:232-233.
85. Quéré P., Dambrine G. Development of anti-tumoural cell-mediated cytotoxicity during the course of Marek's disease in chickens. Ann. Rech. Vet. 1988, 19:193-201.
86. Quéré P., Rivas C., Ester K., Novak R., Ragland W.L. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Arch. Virol. 2005, 150:507-519.
87. Ross L.J.N. Mechanisms of protection conferred by HVT. Resistance and Immunity to Marek's disease 1980, 289-297. Commission of the European Communities, Berlin. P.M. Biggs (Ed.).
88. Sarma G., Greer W., Gildersleeve R.P., Murray D.L., Miles A.M. Field safety and efficacy of in ovo administration of HVT+SB-1 bivalent Marek's disease vaccine in commercial broilers. Avian Dis. 1995, 39:211-217.
89. Sarson A.J., Zhou H., Sharif S. Transcriptional analysis of host responses to Marek's disease viral infection. Viral Immunol. 2006, 19:747-758.
90. Sarson A.J., Abdul-Careem M.F., Read L.R., Brisbin J.T., Sharif S. Expression of cytotoxicity-associated genes in Marek's disease virus-infected chickens. Viral Immunol. 2008, 21:267-272.
91. Schat K.A., Calnek B.W. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys. J. Natl. Cancer Inst. 1978, 61:855-857.
92. Schat K.A., Calnek B.W. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 1978, 60:1075-1082.
93. Schat K.A., Murthy K.K. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen. J. Virol. 1980, 34:130-135.
94. Schat K.A., Pratt W.D., Morgan R., Weinstock D., Calnek B.W. Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 1992, 36:432-439.
95. Schat K.A., Xing Z. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol. 2000, 24:201-221.
96. Schat K.A., Markowski-Grimsrud C.J. Immune responses to Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 2001, 255:91-120.
97. Schat K.A. Marek's disease immunosuppression. Marek's Disease: An Evolving Problem 2004, 142-155. Elsevier, Great Britain. V. Nair, F. Davison (Eds.).
98. Schat K.A., Skinner M.A. Immunosuppressive diseases and immune evasion. Avian Immunology 2008, 299-322. Elsevier, London, San Diego, CA. F. Davidson, B. Kaspers, K.A. Schat (Eds.).
99. Sharma J.M., Witter R.L. The effect of B-cell immunosuppression on age-related resistance of chickens to Marek's disease. Cancer Res. 1975, 35:711-717.
100. Sharma J.M., Okazaki W. Natural killer cell activity in chickens: target cell analysis and effect of antithymocyte serum on effector cells. Infect. Immun. 1981, 31:1078-1085.
101. Sharma J.M. Embryo vaccination of chickens with turkey herpesvirus: characteristics of the target cell of early viral replication in embryonic lung. Avian Pathol. 1987, 16:567-579.
102. Sherman M.A., Goto R.M., Moore R.E., Hunt H.D., Lee T.D., Miller M.M. Mass spectral data for 64 eluted peptides and structural modeling define peptide binding preferences for class I alleles in two chicken MHC-B haplotypes associated with opposite responses to Marek's disease. Immunogenetics 2008, 60:527-541. (Erratum in: Immunogenetics 62, 419).
103. St.Paul M., Brisbin J.T., Abdul-Careem M.F., Sharif S. Immunostimulatory properties of Toll-like receptor ligands in chickens. Vet. Immunol. Immunopathol. 2013, 152:191-199.
104. St.Paul M., Mallick A.I., Read L.R., Villanueva A.I., Parvizi P., Abdul-Careem M.F., Nagy E., Sharif S. Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens. Vaccine 2012, 30:4524-4531.
105. St.Paul M., Paolucci S., Sharif S. Treatment with ligands for Toll-like receptors 2 and 5 induces a mixed T-helper 1 and 2-like response in chicken splenocytes. J. Interferon Cytokine Res. 2012, (Epub. PMID: 23030671).
106. Swaggerty C.L., He H., Genovesa K.J., Duke S.E., Kogut M.H. Loxoribine pretreatment reduces Salmonella enteritidis organ invasion in 1-day-old chickens. Poult. Sci. 2012, 91:1038-1042.
107. Tarpey I., Davis P.J., Sondermeijer P.J., van Geffen C., Verstegen I., Schijns V.E., Kolodsick J., Sundick R. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge. Avian Pathol. 2007, 36:69-74.
108. Wallis J.W., Aerts J., Groenen M.A., Crooijmans R.P., Layman D., Graves T.A., Scheer D.E., et al. A physical map of the chicken genome. Nature 2004, 432:761-764.
109. Wallny H.J., Avila D., Hunt L.G., Powell T.J., Riegert P., Salomonsen J., Skjødt K., Vainio O., Vilbois F., Wiles M.V., Kaufman J. Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC-determined response to Rous sarcoma virus in chickens. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1434-1439.
110. + T cells to increase their abundance during virus infection. J. Exp. Med. 2005, 201:1053-1059.
111. Witter R.L., Nazerian K., Purchase H.G., Burgoyne G.H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 1970, 31:525-538.
112. Witter R.L., Lee L.F. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol. 1984, 13:75-92.
113. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 1997, 41:149-163.
114. Witter R.L. Protective efficacy of Marek's disease vaccines. Marek's Disease 2001, 57-91. Springer-Verlag, Berlin, Heidelberg, NewYork. K. Hirai (Ed.).
115. Xing Z., Schat K.A. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 2000, 100:70-76.
116. Xing Z., Schat K.A. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J. Virol. 2000, 74:3605-3612.